Xeomin is the newest Botulinum Toxin Type A to be launched in New Zealand. Xeomin is marketed by Merz Pharmaceuticals. Touted as a ‘naked’ version of Botox, Merz promise Xeomin to be better tolerated and have a faster response time to Botox and Dysport. At this stage however, it is looking equivalent to the other botulinum toxins on the market. It is a cheaper product and Merz are encouraging practitioners to reduce the price of Xeomin treatments to make it more affordable. We haven’t really had a chance to explore the new kid on the block, but before any products are selected for use at Cosmetic Solutions, they must undergo thorough in-house testing and analysis. Keep an eye on our blog for updates about Xeomin.
